학술논문
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, May 2024, 13(9))
Subject
Language
English
ISSN
20457634